Biohit Oyj (BIOBV.HE)
EUR 2.72
(-1.2%)
EUR 2.72
(-1.2%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 700 Thousand EUR | -25.77% |
| 2022 | 943 Thousand EUR | 326.7% |
| 2021 | 221 Thousand EUR | -41.99% |
| 2020 | 381 Thousand EUR | 32.75% |
| 2019 | 287 Thousand EUR | 386.44% |
| 2018 | 59 Thousand EUR | -22.37% |
| 2017 | 76 Thousand EUR | 0.0% |
| 2016 | - EUR | -100.0% |
| 2015 | 128 Thousand EUR | -50.0% |
| 2014 | 256 Thousand EUR | -33.33% |
| 2013 | 384 Thousand EUR | 0.0% |
| 2012 | 384 Thousand EUR | -92.17% |
| 2011 | 4.9 Million EUR | -48.17% |
| 2010 | 9.46 Million EUR | 5.49% |
| 2009 | 8.97 Million EUR | -1.3% |
| 2008 | 9.09 Million EUR | -0.39% |
| 2007 | 9.12 Million EUR | 18.52% |
| 2006 | 7.7 Million EUR | -5.65% |
| 2005 | 8.16 Million EUR | 98.37% |
| 2004 | 4.11 Million EUR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 400 Thousand EUR | 75.0% |
| 2024 Q1 | 400 Thousand EUR | -42.86% |
| 2023 Q3 | 427 Thousand EUR | -46.63% |
| 2023 FY | 700 Thousand EUR | -25.77% |
| 2023 Q2 | 800 Thousand EUR | 60.0% |
| 2023 Q4 | 700 Thousand EUR | 63.93% |
| 2023 Q1 | 500 Thousand EUR | -46.98% |
| 2022 Q4 | 943 Thousand EUR | 37.46% |
| 2022 FY | 943 Thousand EUR | 326.7% |
| 2022 Q3 | 686 Thousand EUR | -37.64% |
| 2022 Q2 | 1.1 Million EUR | 37.5% |
| 2022 Q1 | 800 Thousand EUR | 261.99% |
| 2021 Q3 | 162 Thousand EUR | -59.5% |
| 2021 Q2 | 400 Thousand EUR | 100.0% |
| 2021 Q1 | 200 Thousand EUR | -47.51% |
| 2021 FY | 221 Thousand EUR | -41.99% |
| 2021 Q4 | 221 Thousand EUR | 36.42% |
| 2020 Q1 | 100 Thousand EUR | -65.16% |
| 2020 Q2 | 300 Thousand EUR | 200.0% |
| 2020 Q3 | 131 Thousand EUR | -56.33% |
| 2020 Q4 | 381 Thousand EUR | 190.84% |
| 2020 FY | 381 Thousand EUR | 32.75% |
| 2019 Q2 | 300 Thousand EUR | 200.0% |
| 2019 FY | 287 Thousand EUR | 386.44% |
| 2019 Q1 | 100 Thousand EUR | 69.49% |
| 2019 Q4 | 287 Thousand EUR | 386.44% |
| 2019 Q3 | 59 Thousand EUR | -80.33% |
| 2018 Q2 | 100 Thousand EUR | 0.0% |
| 2018 Q3 | 42 Thousand EUR | -58.0% |
| 2018 FY | 59 Thousand EUR | -22.37% |
| 2018 Q1 | 100 Thousand EUR | 31.58% |
| 2018 Q4 | 59 Thousand EUR | 40.48% |
| 2017 Q3 | 59 Thousand EUR | -41.0% |
| 2017 FY | 76 Thousand EUR | 0.0% |
| 2017 Q2 | 100 Thousand EUR | 0.0% |
| 2017 Q4 | 76 Thousand EUR | 28.81% |
| 2017 Q1 | 100 Thousand EUR | 0.0% |
| 2016 Q4 | - EUR | 0.0% |
| 2016 Q1 | - EUR | -100.0% |
| 2016 Q2 | 100 Thousand EUR | 0.0% |
| 2016 Q3 | - EUR | -100.0% |
| 2016 FY | - EUR | -100.0% |
| 2015 Q2 | 100 Thousand EUR | 0.0% |
| 2015 Q1 | 100 Thousand EUR | -60.94% |
| 2015 FY | 128 Thousand EUR | -50.0% |
| 2015 Q4 | 128 Thousand EUR | 28.0% |
| 2015 Q3 | 100 Thousand EUR | 0.0% |
| 2014 Q3 | 300 Thousand EUR | 0.0% |
| 2014 FY | 256 Thousand EUR | -33.33% |
| 2014 Q4 | 256 Thousand EUR | -14.67% |
| 2014 Q2 | 300 Thousand EUR | 0.0% |
| 2014 Q1 | 300 Thousand EUR | -21.88% |
| 2013 Q1 | 400 Thousand EUR | 4.17% |
| 2013 Q3 | 400 Thousand EUR | 0.0% |
| 2013 Q4 | 384 Thousand EUR | -4.0% |
| 2013 Q2 | 400 Thousand EUR | 0.0% |
| 2013 FY | 384 Thousand EUR | 0.0% |
| 2012 Q4 | 384 Thousand EUR | -4.0% |
| 2012 Q2 | 400 Thousand EUR | 0.0% |
| 2012 FY | 384 Thousand EUR | -92.17% |
| 2012 Q3 | 400 Thousand EUR | 0.0% |
| 2012 Q1 | 400 Thousand EUR | -91.85% |
| 2011 Q1 | 9.1 Million EUR | -3.86% |
| 2011 Q3 | 11 Million EUR | -3.51% |
| 2011 Q2 | 11.4 Million EUR | 25.27% |
| 2011 Q4 | 4.9 Million EUR | -55.4% |
| 2011 FY | 4.9 Million EUR | -48.17% |
| 2010 Q1 | 9.5 Million EUR | 5.88% |
| 2010 Q2 | 9.5 Million EUR | 0.0% |
| 2010 FY | 9.46 Million EUR | 5.49% |
| 2010 Q3 | 9.5 Million EUR | 0.0% |
| 2010 Q4 | 9.46 Million EUR | -0.37% |
| 2009 Q4 | 8.97 Million EUR | 0.0% |
| 2009 FY | 8.97 Million EUR | -1.3% |
| 2008 FY | 9.09 Million EUR | -0.39% |
| 2007 FY | 9.12 Million EUR | 18.52% |
| 2006 FY | 7.7 Million EUR | -5.65% |
| 2005 FY | 8.16 Million EUR | 98.37% |
| 2004 FY | 4.11 Million EUR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Herantis Pharma Oyj | 34.82 Thousand EUR | -1910.281% |
| Nanoform Finland Oyj | 6.25 Million EUR | 88.813% |